Eric Richman - Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eric Richman since 11/5/2023

Holdings reported by Eric Richman for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 290K $1.12M $3.86 Jul 1, 2024 Direct
Common Stock 14.8K $57.2K $3.86 Jul 1, 2024 By Trust
Stock Option (right to buy) 15K Jun 24, 2024 Direct Common Stock
Restricted Stock Units 0 $2.50 Sep 20, 2023 Direct Common Stock

Transactions reported by Eric Richman for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.